Interaction of Mitoxantrone-Loaded Cholesterol Modified Pullulan Nanoparticles with Human Serum Albumin and Effect on Drug Release

Table 2

Mean size distribution, polydispersity index (PDI), and zeta potential changes of MTO-CHP NPs and HSA at different combination times.

Time (h)
	0	3	6	9	12	15	18
Size (nm)	89.91	109.4	114.3	120.4	144.4	144.7	145.2
PDI	0.508	0.514	0.304	0.285	0.199	0.210	0.231
Zeta (mV)	-15	-7.22	-4.7	-3.74	-3.46	-3.08	-3.073